Larvol Delta - Imara-Announces-First-Patient-Dosed-in-Forte-Phase-2b-Clinical-Trial-of-IMR687-in-BetaThalassemia

IMR-687 - Imara, Inc

http://www.globenewswire.com/news-release/2020/10/16/2109779/0/en/Imara-Announces-First-Patient-Dosed-in-Forte-Phase-2b-Clinical-Trial-of-IMR-687-in-Beta-Thalassemia.html

Oct 16, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next